NCT01557738

Brief Summary

It has well known that diets rich in fruits, vegetables and cocoa products are associated with positive health benefits and these positive effects have been shown to be due to compounds they contain called flavanols. Flavanols have been shown to exert their positive effects by indirectly increasing nitric oxide (NO) bioavailability. NO is a potent vasodilator that is believed to play a role in increasing blood flow to active muscle during exercise. This regulatory process is impaired with healthy aging. The underlying premise to this study is that if NO bioavailability can be increased following flavanol ingestion, will there be a restoration of blood flow during exercise in older individuals? Accordingly, the first part of this research project will compare the acute vascular effects of flavanol ingestion between a young and old group. The investigators have hypothesized that both groups will show an improvement in blood flow to active muscle during exercise, though the magnitude of the change will be greater in the older group. The second part of this project will look at the effects of 4 weeks of daily flavanol ingestion in the old group. The investigators hypothesize that subjects will demonstrate an improvement in blood flow to active muscle during exercise after the 4 week intervention and that the magnitude of the change will be greater than the acute effects. Findings from this proposal will provide evidence for the efficacy of flavanols to be used (as a simple and safe lifestyle intervention) to reverse or combat impaired blood flow regulation in older individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2012

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 19, 2012

Completed
9 months until next milestone

Study Start

First participant enrolled

December 1, 2012

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

June 25, 2014

Status Verified

May 1, 2014

Enrollment Period

1.3 years

First QC Date

March 8, 2012

Last Update Submit

June 24, 2014

Conditions

Keywords

ExerciseBlood FlowNitric OxideAgingAntioxidantFlavanolYoung (18-30 yrs)Aging (60 - 80 yrs)

Outcome Measures

Primary Outcomes (1)

  • Change in femoral blood flow during exercise following flavanol consumption

    Blood flow regulation to active muscles during knee extension exercise can be assessed by using ultrasound to measure blood flow in the femoral artery. This will be done before and after stimulation of the sympathetic nervous system. A baseline value will be obtained and then the measurement will be performed again 2 hours after flavanol ingestion.

    During knee extension exercise, change from baseline in blood flow 2 hours post flavanol ingestion

Secondary Outcomes (1)

  • Change in flow-mediated dilation (FMD) following flavanol consumption

    Change from baseline in FMD 2 hours post flavanol ingestion

Study Arms (4)

Acute effects of flavanol consumption

EXPERIMENTAL

The outcome measurements will be made on all study participants before and 2 hours after consumption of the high flavanol beverage.

Dietary Supplement: High Flavanol Trial

Low Flavanol Trial; acute effects

PLACEBO COMPARATOR

Once again, the outcome measurements will be made on all study participants before and 2 hours after consumption of the low flavanol beverage.

Dietary Supplement: Low Flavanol Trial

Long-term effects of flavanol consumption

EXPERIMENTAL

Only those study participants over 60 years of age will continue with this arm of the trial. The same outcome measures will be performed following 4 weeks of daily consumption of a high flavanol beverage.

Dietary Supplement: High Flavanol Trial; long-term

Low Flavanol Trial; long-term effects

PLACEBO COMPARATOR

Only those study participants over 60 years of age will continue with this arm of the trial. The same outcome measures will be performed following 4 weeks of daily consumption of a low flavanol beverage.

Dietary Supplement: Low Flavanol Trial; long-term effects

Interventions

High Flavanol TrialDIETARY_SUPPLEMENT

The experimental trial (high flavanol content) will involve the consumption of a beverage containing about 1000mg of cocoa flavanols.

Acute effects of flavanol consumption
Low Flavanol TrialDIETARY_SUPPLEMENT

The placebo trial (low flavanol content) will involve the consumption of a beverage containing 75 mg of cocoa flavanols.

Low Flavanol Trial; acute effects

The experimental trial (high flavanol content) will involve the daily consumption of a beverage containing about 1000mg of cocoa flavanols for 4 weeks. Subjects will be provided with 28 packets of the beverage to take home with them.

Long-term effects of flavanol consumption

The placebo trial (low flavanol content) will involve the daily consumption of a beverage containing 75 mg of cocoa flavanols for 4 weeks. Subjects will be provided with 28 packets to take home with them.

Low Flavanol Trial; long-term effects

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and Females between 18 - 30 years old
  • Males and Females between 60 - 80 years old

You may not qualify if:

  • cardiovascular and/or microvascular disease
  • blood clotting disorder
  • pregnant lady
  • current smoker (or regularly smoked within last year)
  • a history of an adverse reaction to cold
  • taking medications known to effect the autonomic nervous system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas at Austin: Environmental and Autonomic Physiology Laboratory

Austin, Texas, 78712, United States

Location

MeSH Terms

Conditions

Motor Activity

Interventions

Time

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Physical Phenomena

Study Officials

  • Michelle Harrison, M.A.

    University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 8, 2012

First Posted

March 19, 2012

Study Start

December 1, 2012

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

June 25, 2014

Record last verified: 2014-05

Locations